Showing results (31-40 of 77) with videos related to
Sort By:
Pageof 8
Cancer Letters|September 1, 1984
Photodynamic inactivation of selected intracellular enzymes by hematoporphyrin derivative and their relationship to tumor cell viability in vitroR Hilf, N W Warne, D B Smail, et al.British Journal of Cancer|June 11, 1999
Delta-aminolaevulinic acid-induced photodynamic therapy inhibits protoporphyrin IX biosynthesis and reduces subsequent treatment efficacy in vitroS L Gibson, J J Havens, M L Nguyen, et al.Oncology Research|January 1, 1992
Chalcogenapyrylium dyes as dual-action sensitizers for photodynamic therapyM R Detty, P B Merkel, S L Gibson, et al.Cancer Biochemistry Biophysics|October 1, 1989
Effects of laser photodynamic therapy on tumor phosphate levels and pH assessed by 31P-NMR spectroscopyS L Gibson, T L Ceckler, T G Bryant, et al.Cancer Research|February 1, 1985
Effects of photosensitization by hematoporphyrin derivative on mitochondrial adenosine triphosphatase-mediated proton transport and membrane integrity of R3230AC mammary adenocarcinomaD S Perlin, R S Murant, S L Gibson, et al.Photochemistry and Photobiology|March 1, 1997
Time-dependent intracellular accumulation of delta-aminolevulinic acid, induction of porphyrin synthesis and subsequent phototoxicityS L Gibson, J J Havens, T H Foster, et al.Cancer|November 1, 1982
A logistic model based on enzyme activities for the prediction of response of breast cancer patients to chemotherapyR Hilf, M L Feldstein, S L Gibson, et al.Cancer|April 15, 1980
The relative importance of estrogen receptor analysis as a prognostic factor for recurrence or response to chemotherapy in women with breast cancerR Hilf, M L Feldstein, S L Gibson, et al.Magnetic Resonance in Medicine|March 1, 1990
In situ assessment of tumor vascularity using fluorine NMR imagingT L Ceckler, S L Gibson, R Hilf, et al.Photochemistry and Photobiology|July 1, 1989
Picosecond fluorescence of R3230AC mammary carcinoma mitochondria after treatment with hematoporphyrin derivative and Photofrin II in vivoC A Hanzlik, R S Knox, S L Gibson, et al.Pageof 8